Five Prime Therapeutics, Inc. Lease, Cost
Five Prime Therapeutics, Inc. reported Lease, Cost of $9.03 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2021-03-22
- Five Prime Therapeutics, Inc. lease, cost for fiscal 2020 was $9.03M, a 14.30% increase from fiscal 2019.
- Five Prime Therapeutics, Inc. lease, cost for fiscal 2019 was $7.90M.
| Period end | Lease, Cost 12 month |
|---|---|
| 2020-12-31 | $9.03M 10-K · filed 2021-03-22 |
| 2019-12-31 | $7.90M 10-K · filed 2021-03-22 |